Yumanity Therapeutics Closes $45 Million Series A Financing
Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline
Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda Pharmaceuticals To Advance New Therapies in ALS
Arsia Therapeutics Inc. and Biogen Sign a Research Collaboration for the Development of Subcutaneous Biologics
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma
Aquinnah Pharmaceuticals Receives $680,000 Grant from NINDS To Advance New Therapies for ALS
EnBiotix, Inc. Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
Vedanta Biosciences Announces License Agreement with RIKEN and other Japanese Institutions for New Immune Boosting Microbiome Technology
